表紙:ラテンアメリカ・中東・アフリカの非経口栄養市場:栄養素別、国別、成長性、COVID-19の影響分析と予測(2021年~2027年)
市場調査レポート
商品コード
1029717

ラテンアメリカ・中東・アフリカの非経口栄養市場:栄養素別、国別、成長性、COVID-19の影響分析と予測(2021年~2027年)

LAMEA Parenteral Nutrition Market By Nutrient Type, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

出版日: | 発行: KBV Research | ページ情報: 英文 64 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
ラテンアメリカ・中東・アフリカの非経口栄養市場:栄養素別、国別、成長性、COVID-19の影響分析と予測(2021年~2027年)
出版日: 2021年08月31日
発行: KBV Research
ページ情報: 英文 64 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ラテンアメリカ・中東・アフリカの非経口栄養剤の市場規模は、予想期間中に9%のCAGRでの成長すると予想されています。

栄養失調は、非経口栄養剤市場の発展の大きな原動力の一つです。ユニセフによると、乳児が生後1,000日の間に栄養失調に陥ると、認知能力の低下や成長の不安定さを招く可能性があるとされています。乳幼児の食事には、ビタミン、デンプン、アミノ酸、ミネラル、脂質などが適切なバランスで含まれていなければなりません。これらの必要な栄養素は、非経口的に投与することができるため、予想期間中、非経口的栄養市場の成長を加速させる可能性があります。

癌などの慢性疾患の急増は、世界的に非経口栄養剤の導入にプラスの影響を与えています。さらに、非経口栄養剤は、治療中の患者の体力、水分補給、エネルギーレベルを向上させるために不可欠な栄養を投与するのに非常に有効です。

ラテンアメリカ・中東・アフリカでは、未熟児の数が急増しています。未熟児は、成長の妨げになったり、感染症にかかったりする危険性が非常に高いです。そのため、未熟児には早期の非経口栄養が重要であり、適切なアミノ酸とエネルギーを供給する必要があります。市場関係者は、この機会を利用して、積極的に地域市場に参入し、競争力を高めるためにさまざまな戦略に投資しています。

超近代的なサプライチェーンソリューションへの高いアクセス性が、今後数年間のこの地域の非経口栄養市場の成長を促進すると予想されます。さらに、診断センターや病院、診療所などのエンドユーザーでは、感染症を防ぎ、衛生レベルを維持するために、非経口栄養剤の導入が進んでいます。これらの要因は、地域の非経口栄養剤市場に新たな成長の道を開くでしょう。

当レポートでは、ラテンアメリカ・中東・アフリカの非経口栄養市場を調査し、市場概要、競合情勢、主要企業のプロファイル、栄養素別・国別の市場分析などの情報を提供しています。

目次

第1章 市場の範囲と調査手法

第2章 市場概要

  • イントロダクション
  • 市場に影響を与える主要因

第3章 ラテンアメリカ・中東・アフリカの非経口栄養剤市場:栄養素別

  • 単回投与アミノ酸溶液
  • 非経口脂質エマルジョン
  • 炭水化物
  • 微量元素
  • ビタミン・ミネラル

第4章 ラテンアメリカ・中東・アフリカの非経口栄養剤市場:国別

  • ブラジル
  • アルゼンチン
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ共和国
  • ナイジェリア
  • その他

第5章 企業プロファイル

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited
図表

LIST OF TABLES

  • TABLE 1 LAMEA Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 2 LAMEA Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 3 LAMEA Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 4 LAMEA Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 5 LAMEA Single Dose Amino Acid Solution Market by Country, 2017 - 2020, USD Million
  • TABLE 6 LAMEA Single Dose Amino Acid Solution Market by Country, 2021 - 2027, USD Million
  • TABLE 7 LAMEA Parenteral Lipid Emulsion Market by Country, 2017 - 2020, USD Million
  • TABLE 8 LAMEA Parenteral Lipid Emulsion Market by Country, 2021 - 2027, USD Million
  • TABLE 9 LAMEA Carbohydrates Market by Country, 2017 - 2020, USD Million
  • TABLE 10 LAMEA Carbohydrates Market by Country, 2021 - 2027, USD Million
  • TABLE 11 LAMEA Trace Elements Market by Country, 2017 - 2020, USD Million
  • TABLE 12 LAMEA Trace Elements Market by Country, 2021 - 2027, USD Million
  • TABLE 13 LAMEA Other Nutrient Type Market by Country, 2017 - 2020, USD Million
  • TABLE 14 LAMEA Other Nutrient Type Market by Country, 2021 - 2027, USD Million
  • TABLE 15 LAMEA Parenteral Nutrition Market by Country, 2017 - 2020, USD Million
  • TABLE 16 LAMEA Parenteral Nutrition Market by Country, 2021 - 2027, USD Million
  • TABLE 17 Brazil Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 18 Brazil Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 19 Brazil Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 20 Brazil Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 21 Argentina Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 22 Argentina Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 23 Argentina Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 24 Argentina Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 25 UAE Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 26 UAE Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 27 UAE Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 28 UAE Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 29 Saudi Arabia Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 30 Saudi Arabia Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 31 Saudi Arabia Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 32 Saudi Arabia Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 33 South Africa Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 34 South Africa Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 35 South Africa Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 36 South Africa Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 37 Nigeria Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 38 Nigeria Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 39 Nigeria Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 40 Nigeria Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 41 Rest of LAMEA Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 42 Rest of LAMEA Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 43 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 44 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 45 Key Information - Vifor Pharma Management Ltd.
  • TABLE 46 Key Information - Baxter International, Inc.
  • TABLE 47 Key Information - Allergan PLC
  • TABLE 48 key Information - B. Braun Melsungen AG
  • TABLE 49 key information - Fresenius SE & Co. KGaA
  • TABLE 50 key information - Grifols S.A.
  • TABLE 51 Key Information - Pfizer, Inc.
  • TABLE 52 key information - ICU Medical, Inc.
  • TABLE 53 Key Information - Anhui Medipharm Co., Ltd.
  • TABLE 54 Key Information - ACULIFE HEALTHCARE PRIVATE LIMITED

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Baxter International, Inc.
目次

The Latin America, Middle East and Africa Parenteral Nutrition Market would witness market growth of 9% CAGR during the forecast period (2021-2027).

Malnutrition is one of the major driving factors for the development of the parenteral nutrition market. As per the UNICEF, if an infant suffers malnutrition during his first 1,000 days of life could result in impaired cognitive ability and unstable growth. The diet of an infant should have an appropriate balance of vitamins, starch, amino acids, minerals, and lipids. These necessary nutrients can be administered through parenteral nutrition, which is likely to accelerate the growth of the parenteral nutrition market during the forecasting period.

The surge in the occurrences of chronic diseases like cancer positively impacts the adoption of parenteral nutrition across the globe. In addition, parenteral nutrition is extremely beneficial in the administration of essential nutrition that is highly helpful for strength, hydration, and energy level among the patients during their treatment.

The region is witnessing a constant surge in the number of premature infants who are highly vulnerable to stunt growth and catching infections. Therefore, early parenteral nutrition is crucial for preterm infants and must transfer appropriate amino acids & energy. The market players are capitalizing on this opportunity by actively entering the regional market and putting investments in different strategies in order to gain a competitive edge.

High accessibility with ultra-modern supply chain solutions is expected to fuel the growth of the regional parenteral nutrition market in the upcoming years. Moreover, the adoption of parenteral nutrition has been increased in end-user verticals such as diagnostic centers, hospitals, and clinics in order to avoid infections and to maintain hygiene levels. Hence, these factors would open new avenues for growth for the regional parenteral nutrition market.

The Single Dose Amino Acid Solution market dominated the South Africa Parenteral Nutrition Market by Nutrient Type in 2020, thereby, achieving a market value of $54.6 million by 2027. The Parenteral Lipid Emulsion market is estimated to grow at a CAGR of 8.8% during (2021 - 2027). Additionally, The Carbohydrates market is expected to witness highest CAGR of 10.3% during (2021 - 2027).

Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.

Scope of the Study

Market Segments covered in the Report:

By Nutrient Type

  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements,
  • Vitamins & Minerals

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Parenteral Nutrition Market, by Nutrient Type
    • 1.4.2 LAMEA Parenteral Nutrition Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 COVID-19 Impact
      • 2.1.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Parenteral Nutrition Market by Nutrient Type

  • 3.1 LAMEA Single Dose Amino Acid Solution Market by Country
  • 3.2 LAMEA Parenteral Lipid Emulsion Market by Country
  • 3.3 LAMEA Carbohydrates Market by Country
  • 3.4 LAMEA Trace Elements Market by Country
  • 3.5 LAMEA Other Nutrient Type Market by Country

Chapter 4. LAMEA Parenteral Nutrition Market by Country

  • 4.1 Brazil Parenteral Nutrition Market
    • 4.1.1 Brazil Parenteral Nutrition Market by Nutrient Type
  • 4.2 Argentina Parenteral Nutrition Market
    • 4.2.1 Argentina Parenteral Nutrition Market by Nutrient Type
  • 4.3 UAE Parenteral Nutrition Market
    • 4.3.1 UAE Parenteral Nutrition Market by Nutrient Type
  • 4.4 Saudi Arabia Parenteral Nutrition Market
    • 4.4.1 Saudi Arabia Parenteral Nutrition Market by Nutrient Type
  • 4.5 South Africa Parenteral Nutrition Market
    • 4.5.1 South Africa Parenteral Nutrition Market by Nutrient Type
  • 4.6 Nigeria Parenteral Nutrition Market
    • 4.6.1 Nigeria Parenteral Nutrition Market by Nutrient Type
  • 4.7 Rest of LAMEA Parenteral Nutrition Market
    • 4.7.1 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type

Chapter 5. Company Profiles

  • 5.1 Vifor Pharma Management Ltd.
    • 5.1.1 Company Overview
    • 5.1.2 Financial Analysis
    • 5.1.3 Research & Development Expenses
  • 5.2 Baxter International, Inc.
    • 5.2.1 Company Overview
    • 5.2.2 Financial Analysis
    • 5.2.3 Regional Analysis
    • 5.2.4 Research & Development Expense
    • 5.2.1 Recent strategies and developments:
      • 5.2.1.1 Partnerships, Collaborations, and Agreements:
      • 5.2.1.2 Product Launches and Product Expansions:
      • 5.2.1.3 Approvals and Trails:
  • 5.3 Allergan PLC (AbbVie)
    • 5.3.1 Company Overview
    • 5.3.2 Financial Analysis
    • 5.3.3 Regional Analysis
    • 5.3.4 Research & Development Expense
  • 5.4 B. Braun Melsungen AG
    • 5.4.1 Company Overview
    • 5.4.2 Financial Analysis
    • 5.4.3 Segmental and Regional Analysis
    • 5.4.4 Research & Development Expenses
  • 5.5 Fresenius SE & Co. KGaA
    • 5.5.1 Company Overview
    • 5.5.2 Financial Analysis
    • 5.5.3 Segmental and Regional Analysis
    • 5.5.4 Research & Development Expenses
  • 5.6 Grifols S.A.
    • 5.6.1 Company Overview
    • 5.6.2 Financial Analysis
    • 5.6.3 Segmental and Regional Analysis
    • 5.6.4 Research & Development Expense
  • 5.7 Pfizer, Inc.
    • 5.7.1 Company Overview
    • 5.7.2 Financial Analysis
    • 5.7.3 Regional Analysis
    • 5.7.4 Research & Development Expenses
  • 5.8 ICU Medical, Inc.
    • 5.8.1 Company Overview
    • 5.8.2 Recent strategies and developments:
      • 5.8.2.1 Partnerships, Collaborations, and Agreements:
  • 5.9 Anhui Medipharm Co., Ltd.
    • 5.9.1 Company Overview
  • 5.10. Aculife Healthcare Private Limited
    • 5.10.1 Company Overview